Turning Ranbaxy Around

Hikma to invest $1B to expand US domestic manufacturing, development of generics

Aenova to boost cold chain capabilities with warehouse at sterile site in Italy

Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals

Biopharma groups seek changes to FDA’s innovative manufacturing strategy